$MNTR
Mentor Capital, Inc. Stock $mntr

$mntr Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224012225 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue		$0.00
YoY Change		-100.0%
Cost Of Revenue		$0.00
YoY Change		-100.0%
Gross Profit		$0.00
YoY Change		-100.0%
Gross Profit Margin
Selling, General & Admin	$271.3K	$1.775M	$1.775M
YoY Change	-67.78%	65.33%	-53.91%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$269.00	-$318.1K	$1.706K
YoY Change	-98.14%	-1738.9%	-97.61%
% of Gross Profit
Operating Expenses	$271.3K	$1.775M	$1.775M
YoY Change	-67.78%	65.33%	-53.91%
Operating Profit	-$271.3K	-$1.775M	-$1.775M
YoY Change	-473.57%	221.2%	9.22%
Interest Expense		$56.45K	$15.85K
YoY Change		-136.9%	-80.24%
% of Operating Profit
Other Income/Expense, Net	$78.59K	$1.290K	$4.863M
YoY Change	-43517.68%		282.09%
Pretax Income	-$192.7K	$3.088M	$3.088M
YoY Change	-366.01%	-537.58%	-975.9%
Income Tax	$15.33K	$8.160K	$8.160K
% Of Pretax Income		0.26%	0.26%
Net Earnings	-$208.0K	$3.158M	$3.158M
YoY Change	320.96%	-805.76%	-769.87%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.01		$0.14
Diluted Earnings Per Share	-$0.01	$0.12	$0.12
COMMON SHARES
Basic Shares Outstanding	24.69M shares	22.69M shares	22.98M shares
Diluted Shares Outstanding	24.69M shares		25.87M shares

Balance Sheet

Concept	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.907M	$3.079M
YoY Change	236.88%	289.74%
Cash & Equivalents	$2.228M	$2.431M
Short-Term Investments	$678.9K	$647.4K
Other Short-Term Assets	$18.00K	$6.510K
YoY Change	-81.31%	-90.14%
Inventory
Prepaid Expenses		$6.508K
Receivables	$2.100K	$1.800K
Other Receivables	$1.030M	$15.00K
Total Short-Term Assets	$3.957M	$4.102M
YoY Change	123.34%	138.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.322K	$1.591K
YoY Change	-99.0%	-98.92%
Goodwill	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Intangibles
YoY Change
Long-Term Investments	$347.7K	$343.3K
YoY Change	3.93%	-21.14%
Other Assets	$347.7K	$343.3K
YoY Change	-89.55%	-89.02%
Total Long-Term Assets	$349.1K	$344.9K
YoY Change	-89.91%	-89.47%
TOTAL ASSETS
Total Short-Term Assets	$3.957M	$4.102M
Total Long-Term Assets	$349.1K	$344.9K
Total Assets	$4.306M	$4.447M
YoY Change	-17.69%	-10.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$77.53K	$3.152K
YoY Change	183.93%	-90.18%
Accrued Expenses	$73.54K	$91.46K
YoY Change	-86.41%	-86.12%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$151.1K	$94.61K
YoY Change	-83.25%	-90.71%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$447.6K	$436.5K
YoY Change	-69.15%	-70.13%
Total Long-Term Liabilities	$447.6K	$436.5K
YoY Change	-82.38%	-80.6%
TOTAL LIABILITIES
Total Short-Term Liabilities	$151.1K	$94.61K
Total Long-Term Liabilities	$447.6K	$436.5K
Total Liabilities	$598.6K	$531.1K
YoY Change	-82.61%	-83.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.396M	-$8.188M
YoY Change	-26.32%	-27.83%
Common Stock	$2.469K	$2.469K
YoY Change	7.63%	7.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.708M	$3.916M
YoY Change
Total Liabilities & Shareholders Equity	$4.306M	$4.447M
YoY Change	-17.69%	-10.95%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$208.0K	$3.158M	$3.158M
YoY Change	320.96%	-805.76%	-769.87%
Depreciation, Depletion And Amortization	$269.00	-$318.1K	$1.706K
YoY Change	-98.14%	-1738.9%	-97.61%
Cash From Operating Activities	-$203.3K	-$1.976M	-$2.017M
YoY Change	-383.83%	99.93%	-1270.04%
INVESTING ACTIVITIES
Capital Expenditures		-$83.06K	$2.291K
YoY Change		-623.05%	-94.36%
Acquisitions
YoY Change
Other Investing Activities	$300.00	$6.966M	$7.069M
YoY Change	-99.72%	1486.44%	1680.09%
Cash From Investing Activities	$300.00	$7.049M	$7.066M
YoY Change	-99.72%	1565.6%	1882.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$7.884K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	-3.113M	-3.408M
YoY Change	-100.0%	3677.45%	1666.49%
NET CHANGE
Cash From Operating Activities	-203.3K	-1.976M	-2.017M
Cash From Investing Activities	300.0	7.049M	7.066M
Cash From Financing Activities	0.000	-3.113M	-3.408M
Net Change In Cash	-203.0K	1.961M	1.641M
YoY Change	-377.78%	-402.85%	388.52%
FREE CASH FLOW
Cash From Operating Activities	-$203.3K	-$1.976M	-$2.017M
Capital Expenditures		-$83.06K	$2.291K
Free Cash Flow		-$1.893M	-$2.020M
YoY Change		88.49%	-1632.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001599117
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi		usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent		usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent		usd
CY2023Q4	MNTR	Disposal Group Including Discontinued Operations Property Plant And Equipment Noncurrent DisposalGroupIncludingDiscontinuedOperationsPropertyPlantAndEquipmentNoncurrent		usd
CY2023Q4	MNTR	Disposal Group Including Discontinued Operation Accumulated Depreciation Noncurrent DisposalGroupIncludingDiscontinuedOperationAccumulatedDepreciationNoncurrent		usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Other Noncurrent Assets DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets		usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent		usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	MNTR	Noncontrolling Interest NoncontrollingInterest		usd
CY2023	us-gaap	Revenues Revenues		usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023	us-gaap	Gross Profit GrossProfit		usd
CY2022	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax		usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023	MNTR	Change In Accrued Interest Income ChangeInAccruedInterestIncome		usd
CY2022	MNTR	Disposal Group Including Discontinued Operation Gain Loss On Sale DisposalGroupIncludingDiscontinuedOperationGainLossOnSale		usd
CY2023	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
CY2023	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables		usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
CY2022	us-gaap	Proceeds From Sale Of Investment Projects ProceedsFromSaleOfInvestmentProjects		usd
CY2022	MNTR	Proceeds From Adjustment On Sale Of Discontinued Operation ProceedsFromAdjustmentOnSaleOfDiscontinuedOperation		usd
CY2022	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments		usd
CY2023	MNTR	Proceeds From Payments To Acquire Management Contract Rights ProceedsFromPaymentsToAcquireManagementContractRights		usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2022	MNTR	Payments From Loans Receivable PaymentsFromLoansReceivable		usd
CY2022	MNTR	Payment Of Capital Adjustment Note Receivable Reduction PaymentOfCapitalAdjustmentNoteReceivableReduction		usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations		usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		usd
CY2023	MNTR	Right Of Use Asset Obtained In Exchange For Finance Lease Liability Discontinued Operations RightOfUseAssetObtainedInExchangeForFinanceLeaseLiabilityDiscontinuedOperations		usd
CY2023	MNTR	Right Of Use Asset Obtained In Exchange For Finance Lease Liability Continued Operations RightOfUseAssetObtainedInExchangeForFinanceLeaseLiabilityContinuedOperations		usd
CY2022	MNTR	Right Of Use Asset Obtained In Exchange For Finance Lease Liability Continued Operations RightOfUseAssetObtainedInExchangeForFinanceLeaseLiabilityContinuedOperations		usd
CY2023	MNTR	Property And Equipment Acquired Via Longterm Debt PropertyAndEquipmentAcquiredViaLongtermDebt		usd
CY2023	MNTR	Property And Equipment Acquired Via Longterm Debt Discontinued Operations PropertyAndEquipmentAcquiredViaLongtermDebtDiscontinuedOperations		usd
CY2023	MNTR	Property And Equipment Acquired Via Longterm Debt Continued Operations PropertyAndEquipmentAcquiredViaLongtermDebtContinuedOperations		usd
CY2022	MNTR	Property And Equipment Acquired Via Longterm Debt Continued Operations PropertyAndEquipmentAcquiredViaLongtermDebtContinuedOperations		usd
CY2023Q4	MNTR	Investment In Account Receivable Impairment InvestmentInAccountReceivableImpairment		usd
CY2022Q4	MNTR	Investment In Account Receivable Impairment InvestmentInAccountReceivableImpairment		usd
CY2023Q4	MNTR	Investment In Account Receivable Current InvestmentInAccountReceivableCurrent		usd
CY2022Q4	MNTR	Investment In Account Receivable Current InvestmentInAccountReceivableCurrent		usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent		usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross		usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross		usd
CY2023Q4	MNTR	Property And Equipment Of Discontinued Operations PropertyAndEquipmentOfDiscontinuedOperations		usd
CY2023Q4	MNTR	Accumulated Depreciation Of Discontinued Operations AccumulatedDepreciationOfDiscontinuedOperations		usd
CY2023	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss		usd
CY2022	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss		usd
CY2023	us-gaap	Revenues Revenues		usd
CY2022	MNTR	Property Additions PropertyAdditions		usd
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations		usd
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	571080	usd
CY2023	dei	Auditor Firm AuditorFirmId	5041
CY2023	dei	Auditor Name AuditorName	BF Borgers CPA PC
CY2023	dei	Auditor Firm AuditorFirmId	5041
CY2023	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2431299	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	283431	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	647363	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1800	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	600	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	15000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1000000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6508	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9375	usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	1426624	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	4101970	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1720030	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	48239	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	45948	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	46648	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	44942	usd
CY2022Q4	MNTR	Disposal Group Including Discontinued Operations Property Plant And Equipment Noncurrent DisposalGroupIncludingDiscontinuedOperationsPropertyPlantAndEquipmentNoncurrent	309777	usd
CY2022Q4	MNTR	Disposal Group Including Discontinued Operation Accumulated Depreciation Noncurrent DisposalGroupIncludingDiscontinuedOperationAccumulatedDepreciationNoncurrent	163905	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1591	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	146878	usd
CY2023Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	238849	usd
CY2022Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	315309	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	104431	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	94431	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Other Noncurrent Assets DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets	2717244	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	343280	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3126984	usd
CY2023Q4	us-gaap	Assets Assets	4446841	usd
CY2022Q4	us-gaap	Assets Assets	4993892	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3152	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7535	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	91460	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19371	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	991050	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	94612	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1017956	usd
CY2023Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	436512	usd
CY2022Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	1153948	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	1095889	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	436512	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2249837	usd
CY2023Q4	us-gaap	Liabilities Liabilities	531124	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3267793	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	11	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	11	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	11	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	11	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24686105	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24686105	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22941357	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22941357	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2469	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2294	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	12101055	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13085993	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8187807	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11345465	usd
CY2022Q4	MNTR	Noncontrolling Interest NoncontrollingInterest	-16723	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3915717	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1726099	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4446841	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4993892	usd
CY2022	us-gaap	Revenues Revenues	35074	usd
CY2022	us-gaap	Gross Profit GrossProfit	35074	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1775210	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	495400	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1775210	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-460326	usd
CY2023	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	4805389	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-170418	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	74780	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	58725	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2484	usd
CY2023	us-gaap	Interest Expense InterestExpense	15847	usd
CY2022	us-gaap	Interest Expense InterestExpense	33878	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	555	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8160	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6768	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	3079759	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-612110	usd
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	83682	usd
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	252800	usd
CY2023	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	5783	usd
CY2022	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	7615	usd
CY2023	MNTR	Income Loss From Discontinued Operations IncomeLossFromDiscontinuedOperations	77899	usd
CY2022	MNTR	Income Loss From Discontinued Operations IncomeLossFromDiscontinuedOperations	245185	usd
CY2023	us-gaap	Profit Loss ProfitLoss	3157658	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-366925	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	104461	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	3157658	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-471386	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.137
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.021
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.122
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.021
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22977395	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22941357	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25865216	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22941357	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2078677	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	14347	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-366925	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1726099	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	40000	usd
CY2023	MNTR	Stock Issued During Period Value Surrender Of Warrants In Payment Of Note Receivable StockIssuedDuringPeriodValueSurrenderOfWarrantsInPaymentOfNoteReceivable	-1016879	usd
CY2023	MNTR	Stock Issued During Period Value Equity Adjustment On Discontinued Operations StockIssuedDuringPeriodValueEquityAdjustmentOnDiscontinuedOperations	16723	usd
CY2023	us-gaap	Profit Loss ProfitLoss	3157658	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3915717	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3915717	usd
CY2023	us-gaap	Profit Loss ProfitLoss	3157658	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-366925	usd
CY2021Q4	MNTR	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuedOperations	192475	usd
CY2022Q4	MNTR	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDiscontinuedOperations	506499	usd
CY2021Q4	MNTR	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDiscontinuedOperations	261464	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	77899	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	245185	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1706	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2079	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	10198	usd
CY2023	MNTR	Amortization Of Discount On Investment In Account Receivable AmortizationOfDiscountOnInvestmentInAccountReceivable	-41741	usd
CY2022	MNTR	Amortization Of Discount On Investment In Account Receivable AmortizationOfDiscountOnInvestmentInAccountReceivable	-56806	usd
CY2022	MNTR	Change In Accrued Interest Income ChangeInAccruedInterestIncome	-86325	usd
CY2023	MNTR	Disposal Group Including Discontinued Operation Gain Loss On Sale DisposalGroupIncludingDiscontinuedOperationGainLossOnSale	4805389	usd
CY2023	MNTR	Gain Loss On Investment In Securities At Fair Value GainLossOnInvestmentInSecuritiesAtFairValue	2484	usd
CY2022	MNTR	Gain Loss On Investment In Securities At Fair Value GainLossOnInvestmentInSecuritiesAtFairValue	833	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-110772	usd
CY2022	us-gaap	Increase Decrease In Finance Receivables IncreaseDecreaseInFinanceReceivables	-306650	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11398	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	15000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2867	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-4383	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1481	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	72089	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-173669	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-16308	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-717436	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	26083	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2426244	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-324670	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	649847	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	176	usd
CY2023	us-gaap	Proceeds From Sale Of Investment Projects ProceedsFromSaleOfInvestmentProjects	6000000	usd
CY2023	MNTR	Proceeds From Adjustment On Sale Of Discontinued Operation ProceedsFromAdjustmentOnSaleOfDiscontinuedOperation	129532	usd
CY2023	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	10000	usd
CY2022	MNTR	Proceeds From Payments To Acquire Management Contract Rights ProceedsFromPaymentsToAcquireManagementContractRights	396666	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2291	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	118201	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	42930	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	5585595	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	439772	usd
CY2023	MNTR	Proceeds From Warrants Converted To Common Stock ProceedsFromWarrantsConvertedToCommonStock	40000	usd
CY2022	MNTR	Proceeds From Warrants Converted To Common Stock ProceedsFromWarrantsConvertedToCommonStock	14347	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7884	usd
CY2023	MNTR	Payments From Loans Receivable PaymentsFromLoansReceivable	1000000	usd
CY2023	MNTR	Payment Of Capital Adjustment Note Receivable Reduction PaymentOfCapitalAdjustmentNoteReceivableReduction	1016879	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-1984763	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	14347	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect Continuing Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectContinuingOperations	1174588	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect Continuing Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffectContinuingOperations	129449	usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	408928	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	497086	usd
CY2023	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	1480861	usd
CY2022	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-83284	usd
CY2023	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-1423008	usd
CY2022	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-207260	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1641369	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	335991	usd
CY2022Q4	MNTR	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuedOperations	283431	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	283431	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	64685	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	302312	usd
CY2023	MNTR	Cash Paid For Interest Discontinued Operations CashPaidForInterestDiscontinuedOperations	-29992	usd
CY2022	MNTR	Cash Paid For Interest Discontinued Operations CashPaidForInterestDiscontinuedOperations	-42483	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	4802905	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-170418	usd
CY2023	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	74780	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	789930	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	453939	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2431299	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	789930	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	506499	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2431299	usd
CY2023	MNTR	Cash Paid For Interest Continued Operations CashPaidForInterestContinuedOperations	34693	usd
CY2022	MNTR	Cash Paid For Interest Continued Operations CashPaidForInterestContinuedOperations	259829	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	15304	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	15663	usd
CY2023	MNTR	Cash Paid For Income Taxes Discontinued Operations CashPaidForIncomeTaxesDiscontinuedOperations	-5784	usd
CY2022	MNTR	Cash Paid For Income Taxes Discontinued Operations CashPaidForIncomeTaxesDiscontinuedOperations	-7615	usd
CY2023	MNTR	Cash Paid For Income Taxes Continued Operations CashPaidForIncomeTaxesContinuedOperations	9520	usd
CY2022	MNTR	Cash Paid For Income Taxes Continued Operations CashPaidForIncomeTaxesContinuedOperations	8048	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	431762	usd
CY2022	MNTR	Right Of Use Asset Obtained In Exchange For Finance Lease Liability Discontinued Operations RightOfUseAssetObtainedInExchangeForFinanceLeaseLiabilityDiscontinuedOperations	-431762	usd
CY2022	MNTR	Property And Equipment Acquired Via Longterm Debt PropertyAndEquipmentAcquiredViaLongtermDebt	22480	usd
CY2022	MNTR	Property And Equipment Acquired Via Longterm Debt Discontinued Operations PropertyAndEquipmentAcquiredViaLongtermDebtDiscontinuedOperations	-22480	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_800_eus-gaap--NatureOfOperations_zFO9FWhgNZr5" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 1 - <span id="xdx_82B_z2MEKRzsrTO5">Nature of operations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Corporate Structure Overview</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mentor Capital, Inc. (“Mentor” or “the Company”) was reincorporated under the laws of the State of <span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20230101__20231231_zyklDbRT5vn7" title="Entity incorporation, state or country code">Delaware</span> in September 2015.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The entity was originally founded as an investment partnership in Silicon Valley, California, by the current CEO in 1985 and subsequently incorporated under the laws of the State of California on <span id="xdx_90C_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20231231_zIUq20rsGP37" title="Entity incorporation, date of incorporation">July 29, 1994</span>. On September 12, 1996, the Company’s offering statement was qualified pursuant to Regulation A of the Securities Act, and the Company began to trade its shares publicly. On August 21, 1998, the Company filed for voluntary reorganization, and on January 11, 2000, the Company emerged from Chapter 11 reorganization. The Company relocated to San Diego, California, and contracted to provide financial assistance and investment into small businesses. On May 22, 2015, a corporation named Mentor Capital, Inc. (“Mentor Delaware”) was incorporated under the laws of the State of Delaware. A shareholder-approved merger between Mentor and Mentor Delaware was approved by the California and Delaware Secretaries of State and became effective September 24, 2015, thereby establishing Mentor as a Delaware corporation. In September 2020, Mentor relocated its corporate office from San Diego, California, to Plano, Texas.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s common stock trades publicly under the trading symbol OTCQB: MNTR.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s current target industry focus includes the classic energy sectors of oil, gas, coal, uranium, and related ventures. Additionally, the Company has residual investments in legal dispute resolution services, collecting on an annuity-like financing, and the collection of a judgment that it intends to continue to pursue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a list of subsidiaries of Mentor Capital, Inc. as of December 31, 2023:</span></p> <p id="xdx_89B_ecustom--ScheduleOfSubsidiaryTableTextBlock_z5a5xTmbCwe2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zse02udUjft1" style="display: none">Schedule of List of Subsidiaries</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Name of Subsidiary</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">% of ownership</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">State in which Incorporated</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 30%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mentor IP, LLC</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MentorIPLLCMember_zGNcjISTc6q4" style="width: 30%; text-align: left" title="Equity method investment, ownership percentage"><span style="font-family: Times New Roman, Times, Serif">100%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--StateInWhichIncorporatedDecription_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MentorIPLLCMember_zdUK0BQwx0Xi" title="State in which incorporated, description">South Dakota</span></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mentor Partner I, LLC</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MentorPartnerILLCMember_z0oHSGjPVsXh" style="text-align: left" title="Equity method investment, ownership percentage"><span style="font-family: Times New Roman, Times, Serif">100%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--StateInWhichIncorporatedDecription_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MentorPartnerILLCMember_z9GX8UTmMIR7" title="State in which incorporated, description">Texas</span></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mentor Partner II, LLC</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MentorPartnerIILLCMember_zrZl0YCO81Og" style="text-align: left" title="Equity method investment, ownership percentage"><span style="font-family: Times New Roman, Times, Serif">100%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--StateInWhichIncorporatedDecription_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MentorPartnerIILLCMember_zj9HR7jQUrcf" title="State in which incorporated, description">Texas</span> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">TWG, LLC</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TWGLLCMember_za9ARAeuIgE2" style="text-align: left" title="Equity method investment, ownership percentage"><span style="font-family: Times New Roman, Times, Serif">100%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--StateInWhichIncorporatedDecription_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--TWGLLCMember_zxoxV8RKn9Ch" title="State in which incorporated, description">Texas</span></span></td></tr> </table> <p id="xdx_8AF_zwaaq42IPmL4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mentor’s <span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MentorIPLLCMember_zB5bxwvakkyb" title="Equity method investment, ownership percentage">100</span>% owned subsidiaries, Mentor IP, LLC (“MCIP”), Mentor Partner I, LLC (“Partner I”), Mentor Partner II, LLC (“Partner II”), and TWG, LLC (“TWG”), are headquartered in Plano, Texas.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MCIP held intellectual property and licensing rights related to one United States and coincident Canadian patent associated with vape pens. On October 24, 2023, the Company divested MCIP’s intellectual property and licensing rights related to the United States and the Canadian patent associated with vape pens. The Company received no payment for its divestment. Patent application national phase maintenance fees were expensed when paid, and there were no assets related to MCIP patents represented on the consolidated financial statements on December 31, 2023 and 2022. Activity had been limited to payment of patent application maintenance fees in Canada.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 27, 2021, the Company and Mentor Partner I entered into a Settlement Agreement and Mutual Release with G FarmaLabs Limited, its affiliated entities, and guarantors (“G Farma Settlors”) to resolve and settle all outstanding claims on an unpaid finance lease receivable and notes receivable of balances of $<span id="xdx_901_eus-gaap--FinanceLeaseLiabilityNoncurrent_iI_c20210827__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GFarmaSettlorsMember__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementAndMutualReleaseMember_z1tgTCneY876" title="Finance lease receivable">803,399</span> and $<span id="xdx_908_ecustom--NotesReceivableRelatedParty_iI_c20210827__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GFarmaSettlorsMember__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementAndMutualReleaseMember_z91KQxKXItue" title="Notes receivable">1,045,051</span>, respectively, plus accrued interest (“Settlement Agreement”). On October 12, 2021, the parties filed a Stipulation for Dismissal and Continued Jurisdiction with the Superior Court of California in the County of Marin. The Court ordered that it retain jurisdiction over the parties under Section 664.6 of the California Code of Civil Procedure to enforce the Settlement Agreement until the performance in full of its terms is met.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mentor Capital, Inc.</b></span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">Notes to Consolidated Financial Statements</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023 and 2022</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2022, September 2022, and October 2022, the G Farma Settlors failed to make monthly payments, and failed to cure each default within 10 days’ notice from Company pursuant to the Settlement Agreement. On July 11, 2023, the Court entered judgment against the G Farma Settlors and in favor of Mentor and Partner I in the amount of $<span id="xdx_90E_eus-gaap--LitigationSettlementAmountAwardedFromOtherParty_c20230711__20230711__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GFarmaSettlorsMember_zYlDGyF6K0a5">2,539,597</span>. The judgment also accrues post-judgment interest at the rate of </span><span id="xdx_908_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20230711__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GFarmaSettlorsMember_z293K1YazH71" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% from July 11, 2023 until such time as the judgment is paid in full.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has retained the reserve on collections of the unpaid lease receivable balance due to the long history of uncertain payments from G Farma. Payments from G Farma will be recognized in Other Income as they are received. We will continue to pursue collection from the G Farma Settlors over time. No recovery payments have been received since October 11, 2022. The $<span id="xdx_904_eus-gaap--LitigationSettlementAmountAwardedFromOtherParty_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GFarmaSettlorsMember_zAlizYgXnxX6">2,539,597 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">judgment and interest receivable of $<span id="xdx_907_eus-gaap--LitigationSettlementInterest_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GFarmaSettlorsMember_zGezXZmgMfK6">120,370 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the twelve months ended December 31, 2023 is fully reserved pending the outcome of the Company’s collection process. See Notes 8, 9, and 18.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 27, 2022, Pueblo West Organics, LLC, a Colorado limited liability company (“Pueblo West”) exercised a lease prepayment option and purchased manufacturing equipment from Partner II for $<span id="xdx_909_eus-gaap--PaymentsToAcquireMachineryAndEquipment_pdp0_c20220927__20220927__dei--LegalEntityAxis__custom--PuebloWestOrganicsLLCMember_zX7rWiMlGQ29">245,369</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. On September 28, 2022 Partner II transferred full title to the equipment to Pueblo West. See Note 9.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 18, 2022, following the filing of a declaratory relief action, Mentor received $<span id="xdx_904_ecustom--ContractualInterestsInLegalRecoveriess_c20221118__20221118__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_z4KQBs68pHTj" title="Contractual interests in legal recoveriess">459,990</span> from Electrum Partners, LLC (“Electrum”) pursuant to a certain November 14, 2022 Settlement Agreement and Mutual Release, following the Company’s October 21, 2022 lawsuit against Electrum and the escrow agent in California Superior Court for the County of San Mateo. The Company applied $<span id="xdx_906_ecustom--ContractualInterestsInLegalRecoveries_iI_c20221118__us-gaap--TypeOfArrangementAxis__custom--RecoveryPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ElectrumPartnersLLCMember_zE5NYFOHtkn2" title="Contractual interests in legal recoveries">196,666</span> to a certain October 30, 2018, Recovery Purchase Agreement and $<span id="xdx_901_ecustom--ContractualInterestsInLegalRecoveries_iI_c20221118__us-gaap--TypeOfArrangementAxis__custom--CapitalAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ElectrumPartnersLLCMember_z5u4hSOiBPpe" title="Contractual interests in legal recoveries">200,000</span> to October 31, 2018 and January 28, 2019 Capital Agreements. The Company applied the remaining $<span id="xdx_90A_ecustom--ContractualInterestsInLegalRecoveries_iI_c20221118__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ElectrumPartnersLLCMember_zmmlQhxMLkjf" title="Contractual interests in legal recoveries">63,324</span> to its $<span id="xdx_909_ecustom--ContractualInterestEquityInterest_iI_c20221118__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ElectrumPartnersLLCMember_zA1uKNMhEfQd" title="Contractual interest equity interest">194,028</span> equity interest in Electrum; this resulted in a $<span id="xdx_90C_eus-gaap--LossOnSaleOfInvestments_pp0p0_c20221118__20221118__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ElectrumPartnersLLCMember_z0zB8fCdedG8" title="Loss on investment">130,704</span> loss on the Company’s investment in Electrum. See Note 10.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 21, 2018, Mentor paid $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20181201__20181221__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NeuCourtIncMember_zSvqVmOc5TGd" title="Stock issued, value">10,000</span> to purchase <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20181201__20181221__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NeuCourtIncMember_zQ8c5Cwj1mm9" title="Stock issued, shares">500,000</span> shares of NeuCourt, Inc. (“NeuCourt”) common stock, representing approximately <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_pid_dp_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NeuCourtIncMember_z7H9Hf7EzWkl" title="Entity issued and outstanding common stock, percentage">6.13</span>% of NeuCourt’s issued and outstanding common stock at December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since 2003, the Company has held an interest in a facilities operations company, Waste Consolidators Inc. (“WCI”). The Company purchased a 50% interest in WCI in 2003 and increased its ownership stake by 1% in 2014. On October 4, 2023, the Company sold the entirety of its ownership interest in WCI for $<span id="xdx_906_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_pid_c20231004__us-gaap--IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis__custom--WasteConsolidatorsIncMember_z8pZBipFtU75">6,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Following the sale, the Company received no new income from WCI and had no further involvement or continuing influence over its operations. As a result of this sale, our facilities operations segment was eliminated, and its results of operations, assets, and liabilities were excluded from our continuing operations. Therefore, WCI is presented as a discontinued operation in our consolidated financial statements. See Note 3.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	1994-07-29
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8187807	usd
CY2022Q1	MNTR	Impairment Of Investment ImpairmentOfInvestment	116430	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	41930	usd
CY2022	MNTR	Impairment Of Investments1 ImpairmentOfInvestments1	-139148	usd
CY2023Q1	MNTR	Purchase Obligation Due In Current Year PurchaseObligationDueInCurrentYear	117000	usd
CY2023Q1	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	117000	usd
CY2023Q1	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	117000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zgRH54NsRsP7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_zaWCLYL0fYM7">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates, assumptions, and judgments that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of our consolidated financial statements, and the reported amount of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant estimates relied upon in preparing these consolidated financial statements include revenue recognition, accounts and notes receivable reserves, expected future cash flows used to evaluate the recoverability of long-lived assets, estimated fair values of long-lived assets used to record impairment charges related to investments, goodwill, amortization periods, accrued expenses, and recoverability of the Company’s net deferred tax assets and any related valuation allowance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. Acquisitions and divestitures are not announced until certain. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Actual results may differ from management’s estimates if past experience or other assumptions do not turn out to be substantially accurate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q1	MNTR	Impairment Of Investment ImpairmentOfInvestment	116430	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	41930	usd
CY2023Q1	MNTR	Purchase Obligation Due In Current Year PurchaseObligationDueInCurrentYear	117000	usd
CY2023Q1	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	117000	usd
CY2023Q1	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	117000	usd
CY2023Q1	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	117000	usd
CY2023	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<p id="xdx_843_eus-gaap--PropertyPlantAndEquipmentImpairment_z0NhB1UMS4b5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_860_zh9XpA9V6V4j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Property and equipment</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are recorded at cost less accumulated depreciation. Depreciation is computed using the declining balance method over the estimated useful lives of various classes of property. The estimated lives of the property and equipment are generally as follows: computer equipment, <span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zHuhDTIaClh8" title="Property and equipment, useful life">3</span> years to <span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_z44FO3K5ATQg" title="Property and equipment, useful life">5</span> years; furniture and equipment, <span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zL2myxUfAqJc" title="Property and equipment, useful life">7</span> years; and vehicles and trailers, <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember__srt--RangeAxis__srt--MinimumMember_zYFxPjag07C5" title="Property and equipment, useful life">4</span> years to <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember__srt--RangeAxis__srt--MaximumMember_zogHkYURrpj6" title="Property and equipment, useful life">5</span> years. Depreciation on vehicles used by our discontinued operation to service its customers is included in the cost of goods sold. All other depreciation is included in selling, general, and administrative costs in the consolidated income statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures for major renewals and improvements are capitalized, while minor replacements, maintenance, and repairs, which do not extend the asset lives, are charged to operations as incurred. Upon sale or disposition, the cost and related accumulated depreciation are removed from the accounts, and any gain or loss is included in operations. The Company continually monitors events and changes in circumstances that could indicate that the carrying balances of its property and equipment may not be recoverable in accordance with the provisions of ASC 360, <i>“Property, Plant, and Equipment.” </i>When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. See Note 6.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reviews intangible assets subject to amortization quarterly to determine if any adverse conditions exist or if a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall, or an adverse action or assessment by a regulator. If an impairment indicator exists, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset (asset group) exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset (asset group), the Company will write the carrying value down to the fair value in the period identified.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2014Q1	us-gaap	Goodwill Goodwill	102040	usd
CY2023	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	4805389	usd
CY2023	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	Fleet and vehicle leases were entered into prior to January 1, 2019, and under ASC 840 guidelines, they had 4-year terms and were classified as operating leases. Fleet leases entered into beginning January 1, 2019, under ASC 842 guidelines, were expected to be extended to 5-year terms and are classified as finance leases.
CY2023Q4	us-gaap	Goodwill Goodwill	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	0	usd
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	4250000	shares
CY2023	MNTR	Effect Of Dilutive Common Stock Equivalents EffectOfDilutiveCommonStockEquivalents	2887821	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7000000	shares
CY2022Q4	MNTR	Accumulated Depreciation Of Discontinued Operations AccumulatedDepreciationOfDiscontinuedOperations	-163905	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1591	usd
CY2023Q1	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	117000	usd
CY2023Q4	MNTR	Investment In Account Receivable Face Value InvestmentInAccountReceivableFaceValue	285400	usd
CY2022Q4	MNTR	Investment In Account Receivable Face Value InvestmentInAccountReceivableFaceValue	403600	usd
CY2023Q4	MNTR	Investment In Account Receivable Unamortized Discount InvestmentInAccountReceivableUnamortizedDiscount	46551	usd
CY2022Q4	MNTR	Investment In Account Receivable Unamortized Discount InvestmentInAccountReceivableUnamortizedDiscount	88291	usd
CY2023Q4	MNTR	Investment In Account Receivable Net InvestmentInAccountReceivableNet	238849	usd
CY2022Q4	MNTR	Investment In Account Receivable Net InvestmentInAccountReceivableNet	315309	usd
CY2023Q4	MNTR	Investment In Account Receivable Noncurrent InvestmentInAccountReceivableNoncurrent	238849	usd
CY2022Q4	MNTR	Investment In Account Receivable Noncurrent InvestmentInAccountReceivableNoncurrent	315309	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	41741	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	56806	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	1015000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	33626	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	31335	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	14613	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	146878	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	14613	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	48239	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	45948	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	46648	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	44942	usd
CY2022Q4	MNTR	Property And Equipment Of Discontinued Operations PropertyAndEquipmentOfDiscontinuedOperations	-309777	usd
CY2019	us-gaap	Finance Lease Impairment Loss FinanceLeaseImpairmentLoss	783880	usd
CY2020Q4	MNTR	Lease Equipment At Cost LeaseEquipmentAtCost	622569	usd
CY2023	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	2484	usd
CY2022	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	833	usd
CY2022	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	833	usd
CY2023	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-2484	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	1998-08-21
CY2023Q4	MNTR	Warrant Redemption Price WarrantRedemptionPrice	0.10
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P14Y6M
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P15Y6M
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.64
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.94
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	2000000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	90410	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	180200	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2023Q4	MNTR	Warrant Redemption Price WarrantRedemptionPrice	0.10
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-460326	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2014Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	300000	shares
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	300000	shares
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	44748	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	MNTR	Accrued Salaries And Benefits AccruedSalariesAndBenefits	30517	usd
CY2022Q4	MNTR	Accrued Salaries And Benefits AccruedSalariesAndBenefits	914072	usd
CY2023Q4	MNTR	Accrued Retirement And Other Benefits AccruedRetirementAndOtherBenefits	667648	usd
CY2022Q4	MNTR	Accrued Retirement And Other Benefits AccruedRetirementAndOtherBenefits	501529	usd
CY2023Q4	MNTR	Offset By Shareholder Advance OffsetByShareholderAdvance	-261653	usd
CY2022Q4	MNTR	Offset By Shareholder Advance OffsetByShareholderAdvance	-261653	usd
CY2023Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	436512	usd
CY2022Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	1153948	usd
CY2023Q4	MNTR	Incentive Fee Percentage IncentiveFeePercentage	0.01	pure
CY2023Q4	us-gaap	Capitalization Longterm Debt And Equity CapitalizationLongtermDebtAndEquity	260000	usd
CY2023Q4	MNTR	Market Capitalization Rate MarketCapitalizationRate	0.005	pure
CY2023	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1
CY2023	us-gaap	Incentive Fee Expense IncentiveFeeExpense	0	usd
CY2022	us-gaap	Incentive Fee Expense IncentiveFeeExpense	0	usd
CY2023	us-gaap	Loss Contingency Lawsuit Filing Date LossContingencyLawsuitFilingDate	May 28, 2019
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1775210	usd
CY2023	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	74780	usd
CY2023	us-gaap	Interest Expense InterestExpense	15847	usd
CY2023	MNTR	Property Additions PropertyAdditions	2291	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1706	usd
CY2023Q4	us-gaap	Assets Assets	4446841	usd
CY2022	us-gaap	Revenues Revenues	35074	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-460326	usd
CY2022	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	58726	usd
CY2022	us-gaap	Interest Expense InterestExpense	33878	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2079	usd
CY2022Q4	us-gaap	Assets Assets	4993892	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1775210	usd
CY2022	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	58726	usd
CY2023	us-gaap	Interest Expense InterestExpense	15847	usd
CY2022	us-gaap	Interest Expense InterestExpense	33878	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1291	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	555	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3087919	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-605342	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-273400	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	107700	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1100	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	18300	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	272300	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	126000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	13943	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	14383	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3087919	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-605342	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	MNTR	Income Tax Reconciliation Computed Expected Tax Provision Benefit Continuing Operations IncomeTaxReconciliationComputedExpectedTaxProvisionBenefitContinuingOperations	648463	usd
CY2022	MNTR	Income Tax Reconciliation Computed Expected Tax Provision Benefit Continuing Operations IncomeTaxReconciliationComputedExpectedTaxProvisionBenefitContinuingOperations	-127122	usd
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	83682	usd
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	252800	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	MNTR	Income Tax Reconciliation Computed Expected Tax Provision Benefit Discontinued Operations IncomeTaxReconciliationComputedExpectedTaxProvisionBenefitDiscontinuedOperations	17573	usd
CY2022	MNTR	Income Tax Reconciliation Computed Expected Tax Provision Benefit Discontinued Operations IncomeTaxReconciliationComputedExpectedTaxProvisionBenefitDiscontinuedOperations	53088	usd
CY2023	MNTR	Income Tax Reconciliation Computed Expected Tax Provision Benefit IncomeTaxReconciliationComputedExpectedTaxProvisionBenefit	666036	usd
CY2022	MNTR	Income Tax Reconciliation Computed Expected Tax Provision Benefit IncomeTaxReconciliationComputedExpectedTaxProvisionBenefit	-74034	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-393736	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	200034	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	272300	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	126000	usd
CY2023Q1	MNTR	Purchase Obligation Due In Current Year PurchaseObligationDueInCurrentYear	117000	usd
CY2022Q1	MNTR	Impairment Of Investment ImpairmentOfInvestment	116430	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	41930	usd

Files In Submission

Name	View Source	Status
0001493152-24-012225-index-headers.html	Edgar Link	pending
0001493152-24-012225-index.html	Edgar Link	pending
0001493152-24-012225.txt	Edgar Link	pending
0001493152-24-012225-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-1_001.jpg	Edgar Link	pending
ex10-1_002.jpg	Edgar Link	pending
ex10-1_003.jpg	Edgar Link	pending
ex10-1_004.jpg	Edgar Link	pending
ex10-1_005.jpg	Edgar Link	pending
ex10-1_006.jpg	Edgar Link	pending
ex10-1_007.jpg	Edgar Link	pending
ex10-1_008.jpg	Edgar Link	pending
ex10-1_009.jpg	Edgar Link	pending
ex10-1_010.jpg	Edgar Link	pending
ex10-1_011.jpg	Edgar Link	pending
ex10-1_012.jpg	Edgar Link	pending
ex10-1_013.jpg	Edgar Link	pending
ex10-1_014.jpg	Edgar Link	pending
ex10-1_015.jpg	Edgar Link	pending
ex10-1_016.jpg	Edgar Link	pending
ex10-1_017.jpg	Edgar Link	pending
ex10-1_018.jpg	Edgar Link	pending
ex10-1_019.jpg	Edgar Link	pending
ex10-1_020.jpg	Edgar Link	pending
ex10-1_021.jpg	Edgar Link	pending
ex10-1_022.jpg	Edgar Link	pending
ex10-1_023.jpg	Edgar Link	pending
ex10-1_024.jpg	Edgar Link	pending
ex10-1_025.jpg	Edgar Link	pending
ex10-1_026.jpg	Edgar Link	pending
ex10-1_027.jpg	Edgar Link	pending
ex10-1_028.jpg	Edgar Link	pending
ex10-1_029.jpg	Edgar Link	pending
ex10-1_030.jpg	Edgar Link	pending
ex10-1_031.jpg	Edgar Link	pending
ex10-1_032.jpg	Edgar Link	pending
ex10-1_033.jpg	Edgar Link	pending
ex10-1_034.jpg	Edgar Link	pending
ex10-1_035.jpg	Edgar Link	pending
ex10-1_036.jpg	Edgar Link	pending
ex10-1_037.jpg	Edgar Link	pending
ex10-1_038.jpg	Edgar Link	pending
ex10-1_039.jpg	Edgar Link	pending
ex10-1_040.jpg	Edgar Link	pending
ex10-1_041.jpg	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-4.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mntr-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
mntr-20231231_cal.xml	Edgar Link	unprocessable
mntr-20231231_def.xml	Edgar Link	unprocessable
mntr-20231231_lab.xml	Edgar Link	unprocessable
mntr-20231231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MNTR
Mentor Capital, Inc. Stock $mntr

2024 Q1 Form 10-K Financial Statement

#000149315224012225 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNTR Mentor Capital, Inc. Stock $mntr

2024 Q1 Form 10-K Financial Statement

#000149315224012225 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNTR
Mentor Capital, Inc. Stock $mntr